Clinical Trials Browser

Phase 1/2 × Colorectal Neoplasms × brivanib × Clear all

NCT00594984 2015-11-04

Phase I/II Combination With Irinotecan- Erbitux

Phase 1/2 Completed

Gastrointestinal

Colorectal Neoplasms